Back to results
US 2012/0269857 A1Published application
Analogs of alpha galactosylceramide and uses thereof
AssigneeLudwig Institute for Cancer Research
InventorsVincenzo CERUNDOLO, Richard Schmidt, Gopal Reddy, Rengarajan Balamurugan, Gerd Ritter, Gurdyal Besra, Mariolina Salio, Jonathan Silk
Life of this patent
Estimating the term…
Abstract
Compounds of formula wherein the variables are defined in the specification, are used in compositions which stimulate T cell responses.
Claims12
1-18. (canceled)
A composition useful as an immune stimulant comprising a compound of formula:
- in which
- R1 represents a hydrophobic moiety adapted to occupy the C′ channel of human CD1d,
- R2 represents a hydrophobic moiety adapted to occupy the A′ channel of human CD1d, such that R1 fills at least at least 30% of the occupied volume of the C′ channel compared to the volume occupied by the terminal nC14H29 of the sphingosine chain of α-galactosylceramide when bound to human CD1d and R2 fills at least 30% of the occupied volume of the A′ channel compared to the volume occupied by the terminal nC25H51 of the acyl chain of α-galactosylceramide when bound to human CD
- R3 represents hydrogen or OH,
- Ra and Rb each represent hydrogen and in addition, when R3 represents hydrogen, Ra and Rb together may form a single bond,
- X represents or —CHA(CHOH)nY or —P(═O)(O−)OCH2(CHOH)mY, in which Y represents CHB1B25
- n represents an integer from 1 to 4, m represents 0 or 1,
- A represents hydrogen,
- one of B1 and B2 represents H, OH or phenyl, and the other represents hydrogen or one of B1 and B2 represents hydroxyl and the other represents phenyl,
- in addition, when n represents 4, then A together with one of B1 and B2 together forms a single bond and the other of B1 and B2 represents H, OH or OSO3H
- and pharmaceutically acceptable salts thereof, and
- a TLR ligand.
9 more elements
A kit useful in stimulating the immune system of a subject in need thereof, comprising a separate portion of each of:
- (i) a compound of formula:
- in which
- R1 represents a hydrophobic moiety adapted to occupy the C′ channel of human CD1d,
- R2 represents a hydrophobic moiety adapted to occupy the A′ channel of human CD1d, such that R1 fills at least at least 30% of the occupied volume of the C′ channel compared to the volume occupied by the terminal nC14H29 of the sphingosine chain of α-galactosylceramide when bound to human CD1d and R2 fills at least 30% of the occupied volume of the A′ channel compared to the volume occupied by the terminal nC25H51 of the acyl chain of α-galactosylceramide when bound to human CD1d
- R3 represents hydrogen or OH,
- Ra and Rb each represent hydrogen and in addition, when R3 represents hydrogen, Ra and Rb together may form a single bond,
- X represents or —CHA(CHOH)nY or —P(═O)(O−)OCH2(CHOH)mY, in which Y represents CHB1B2,
- n represents an integer from 1 to 4, m represents 0 or 1,
- A represents hydrogen,
- one of B1 and B2 represents H, OH or phenyl, and the other represents hydrogen or one of B1 and B2 represents hydroxyl and the other represents phenyl,
- in addition, when n represents 4, then A together with one of B1 and B2 together forms a single bond and the other of B1 and B2 represents H, OH or OSO3H
- and pharmaceutically acceptable salts thereof
- (ii) a TLR ligand, and
- (iii) a container means for holding (i) and (ii).
11 more elements
Dependencies are inferred from the claim text.